Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Friday 05 September, 2008

Lipoxen PLC

Holding(s) in Company

RNS Number : 8725C
Lipoxen PLC
05 September 2008

Lipoxen plc 

('Lipoxen' or the 'Company')

Holdings in company

The Company was informed on 4 September that on 15 July 2008 FDS Pharma Ass ('FDS') and related parties (together being 'FDS Group') disposed of 229,648 ordinary shares of 0.5p each ('Ordinary Shares') at 22.5 pence eachThe Company was also in formed on 4 September that on 18 July FDS Group sold 120,000 Ordinary Shares at 19.5 pence each. Following these disposals FDS Group is interested in 43,355,316 Ordinary Shares, representing 36.21 per cent of the issued Ordinary Share capital in the Company.

Lipoxen was also notified on 4 September 2008 that the FDS has changed their custodian which has resulted in a change in the legal ownership of 32,584,485 Ordinary Shares. However, the beneficial ownership of these Ordinary Shares has not changed. As a consequence FDS Group still has a beneficial interest in 43,355,316 Ordinary Shares representing 36.21 per cent of the issued Ordinary Share capital in the Company.


Lipoxen plc

+44 (0)20 7691 3583

Scott Maguire, Chief Executive Director

Colin Hill, Finance Director

Landsbanki Securities (UK) Limited 

(nominated adviser)

+44 (0)20 7426 9000

Shaun Dobson / Claes Spång

Citigate Dewe Rogerson

+44 (0)20 7638 9571

David Dible / Heather Keohane

This information is provided by RNS
The company news service from the London Stock Exchange